Abstract
The current treatments for children with multiple sclerosis (MS) was a theme explored in a session at this year’s conference of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), which took place on the 26th–28th October 2022. The speakers shared their insights into the management and clinical consequences of MS in children, and discussed perspectives as to why immunomodulatory treatment is different in children with MS. The session was a Rogier Hintzen Memorial session, dedicated to the memory of the renowned Professor of Neurology from Rotterdam, the Netherlands, whose research focused on MS and neurological disorders of the central nervous system and who was one of the first neurologists to recognise the special needs of children with MS.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
